COVID-19 Vaccine Acceptance: We Need to Start Now.
COVID-19 Vaccine Acceptance: We Need to Start Now.
复制标题
DOI：
10.1093/ofid/ofaa658
复制
发表时间：
2021-03
影响因子：
4.2
通讯作者：
Smith TC
中科院分区：
文献类型：
--
作者：
Kuppalli K;Brett-Major DM;Smith TC
从这个角度来看，我们讨论了开发疫苗以帮助遏制严重急性呼吸综合征冠状病毒2传播的重要性。问题依然存在：一旦研发出安全有效的疫苗，公众是否愿意接种？我们提供的信息来自首批跟踪民意调查之一，以评估公众对2019年可能的冠状病毒病疫苗的态度和看法，这表明公众对潜在疫苗的犹豫，对加速临床试验的担忧以及对疫苗审批过程的不安。公共卫生专家、政府官员、倡导者和科学界的其他人应该尊重犹豫的信号和沟通的敏感性，不仅要将经验教训应用于我们如何传达信息，而且要应用于我们如何构建这种急需的疫苗，如果我们要成功地使用这种疫苗的话。
In this perspective, we discuss the importance of developing a vaccine to help curb transmission of severe acute respiratory syndrome coronavirus 2. The question remains: Once a safe and effective vaccine is developed, will the public be willing to get it? We present information from one of the first tracking polls to assess public attitudes and perceptions toward a possible coronavirus disease 2019 vaccine that suggests public hesitancy over a potential vaccine, concern regarding accelerating clinical trials, and unease over the vaccine approval process. Public health experts, government officials, advocates, and others in the scientific community should respect the signals of hesitancy and communicate sensitivity, applying lessons not only to how we message, but also in how we build this urgently needed vaccine if we are to have successful uptake once available.
影响因子：
4.2
作者：
Smith TC
通讯作者：
Smith TC
影响因子：
2.1
作者：
Tomljenovic, Lucija;Shaw, Christopher A.
通讯作者：
Shaw, Christopher A.